Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 2
2005 1
2006 3
2007 6
2008 7
2009 5
2010 9
2011 13
2012 14
2013 13
2014 17
2015 21
2016 23
2017 14
2018 13
2019 19
2020 26
2021 29
2022 28
2023 25
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Results by year

Filters applied: . Clear all
Page 1
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Zhang P, Zhang Q, Tong Z, Sun T, Li W, Ouyang Q, Hu X, Cheng Y, Yan M, Pan Y, Teng Y, Yan X, Wang Y, Xie W, Zeng X, Wang X, Hu C, Geng C, Zhang H, Li W, Wu X, Zhong J, Xu J, Shi Y, Wei W, Bayaxi N, Zhu X, Xu B. Zhang P, et al. Lancet Oncol. 2023 Jun;24(6):646-657. doi: 10.1016/S1470-2045(23)00172-9. Epub 2023 May 11. Lancet Oncol. 2023. PMID: 37182538 Clinical Trial.
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial.
Xu B, Zhang Q, Zhang P, Hu X, Li W, Tong Z, Sun T, Teng Y, Wu X, Ouyang Q, Yan X, Cheng J, Liu Q, Feng J, Wang X, Yin Y, Shi Y, Pan Y, Wang Y, Xie W, Yan M, Liu Y, Yan P, Wu F, Zhu X, Zou J; DAWNA-1 Study Consortium. Xu B, et al. Among authors: zhang p. Nat Med. 2021 Nov;27(11):1904-1909. doi: 10.1038/s41591-021-01562-9. Epub 2021 Nov 4. Nat Med. 2021. PMID: 34737452 Clinical Trial.
Current Development of Glioblastoma Therapeutic Agents.
Wang Z, Peet NP, Zhang P, Jiang Y, Rong L. Wang Z, et al. Among authors: zhang p. Mol Cancer Ther. 2021 Sep;20(9):1521-1532. doi: 10.1158/1535-7163.MCT-21-0159. Epub 2021 Jun 25. Mol Cancer Ther. 2021. PMID: 34172531 Review.
Current therapy and development of therapeutic agents for lung cancer.
Wang Z, Kim J, Zhang P, Galvan Achi JM, Jiang Y, Rong L. Wang Z, et al. Among authors: zhang p. Cell Insight. 2022 Feb 9;1(2):100015. doi: 10.1016/j.cellin.2022.100015. eCollection 2022 Apr. Cell Insight. 2022. PMID: 37193130 Free PMC article. Review.
Metabolic surgery in China: present and future.
Tu Y, Bao Y, Zhang P. Tu Y, et al. Among authors: zhang p. J Mol Cell Biol. 2021 Jul 7;13(8):594-609. doi: 10.1093/jmcb/mjab039. Online ahead of print. J Mol Cell Biol. 2021. PMID: 34240190 Free PMC article.
276 results